Ms Patricia Umlauf Dawson, LCSW | |
23668 Front Street, Accomac, VA 23301 | |
(757) 787-3080 | |
Not Available |
Full Name | Ms Patricia Umlauf Dawson |
---|---|
Gender | Female |
Speciality | Psychologist - Group Psychotherapy |
Location | 23668 Front Street, Accomac, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770786790 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TP2701X | Psychologist - Group Psychotherapy | 0904002619 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Patricia Umlauf Dawson, LCSW Po Box 7050, Richmond, VA 23221-0050 Ph: (804) 514-8696 | Ms Patricia Umlauf Dawson, LCSW 23668 Front Street, Accomac, VA 23301 Ph: (757) 787-3080 |
News Archive
MedClean Technologies, the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has signed a Partnership Agreement with Bear Consulting aimed at implementing an expense reduction program that could save the Federal Government more than $100 million over the next decade.
The American Board of Medical Specialties announced today a contract from the U.S. Department of Health and Human Services to align the meaningful use of health information technology and the ABMS Maintenance of Certification program, which was created by ABMS and its 24 Member Boards to promote lifelong learning and self assessment for physician specialists. The contract was awarded by the HHS Office of the National Coordinator for HIT.
Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.
Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.
› Verified 3 days ago